#POC HbA1C Testing Market POC HbA1C Testing Market Size POC HbA1C Testing Market Share POC HbA1C Testing Market Growth POC HbA1C Testing Mark

[spookysaladchaos]

Global Top 5 Companies Accounted for 77% of total POC HbA1C Testing market (QYResearch, 2021)

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

In this report, we mainly study the devices for POC HbA1C Testing without services.

According to the new market research report “Global POC HbA1C Testing  Market Report 2023-2029”, published by QYResearch, the global POC HbA1C Testing  market size is projected to reach USD 0.85 billion by 2029, at a CAGR of 7.8% during the forecast period.

Figure.   Global POC HbA1C Testing Market Size (US$ Million), 2018-2029

Figure.   Global POC HbA1C Testing Top 5 Players Ranking and Market Share（Based on data of 2021, Continually updated）

The global key manufacturers of POC HbA1C Testing  include Abbott, Siemens, Roche, Sinocare (PTS Diagnostics), Trinity Biotech, EKF Diagnostics, Bio-Rad, SD Biosensor, HUMAN Diagnostics, Erba Diagnostics, etc. In 2021, the global top five players had a share approximately 77.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

For more information, please contact the following e-mail address:

Email: global@qyresearch.com

Website: https://www.qyresearch.com

[mrfrblogresearch02]

Point of Care Diagnostics/Testing Market Demand, Cost Analysis And Latest Advancement in Medical Sector 2027

Market Highlights:

According to MRFR analysis, the global point of care diagnostics/testing Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The global point of care diagnostics/testing market is driven by several factors, such as increasing demand for remote diagnosis, rising demand for early-stage diagnosis products, and growing demand for minimally or non-invasive diagnostic products. Other factors such as the introduction of mobile healthcare technologies and wearable diagnostic devices, the emergence of new technologies for monitoring and imaging are creating opportunities for the market players.

The market players are involved in various strategic collaborations, mergers & acquisitions, product launches, cooperative development of the product, and investing in stock to expand their worldwide presence. For instance, in July 2020, Becton, Dickinson and Company (US) launched a rapid POC antigen test to diagnose SARS-CoV-2 in 15 minutes. In June 2020, Celltrion Group (South Korea) announced to launch COVID-19 POC antigen testing kit. Furthermore, the prominent players focus on employee satisfaction, transforming their research utilities, and diversifying their distribution network. These factors will augment the market growth and will increase the market share during the forecast period. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: North America is estimated to dominate the point of care diagnostics/testing market, owing to the increasing demand for virtual and convenient diagnostic solutions, enhancement in healthcare regulations, and growing awareness about wellness and healthcare among the young population. Furthermore, the involvement/adoption of strategies like mergers & acquisitions by key players, government partnerships, and the development of new products are also propelling the market growth. Europe embraces the second-largest position in the point of care diagnostics/testing market due to the increasing number of IVD testing, molecular diagnostics, and the prevalence of respiratory diseases across the region. The industry players are involved in various business activities such as product launches, mergers and acquisitions, partnerships, and other commercial approaches. For instance, in May 2020, ProciseDx (US) launched 510k filing for CRP test in Europe for gastrointestinal disorders. The product launch aims to offer high lab-quality results to the patients. In addition, in July 2021, QuantuMDx (Singapore) launched Q-POC, a point-of-care diagnostics to detect SARS-CoV-2. The product is easy to use, affordable, and offers results in 30 minutes. Such business parameters are expected to propel the point of care diagnostic market in the forecast period.

Asia-Pacific is projected to be the fastest-growing regional market during the study period due to increasing demand for diagnostic tests such as blood gas tests, rapid blood coagulation tests, pregnancy tests, drug abuse screening, rapid diagnosis of cardiac markers, blood glucose testing, electrolyte analysis, urine analysis, and dry biochemical tests across the region. In addition, the increasing demand for multiple diagnostic devices coupled with the rising demand for accurate and efficient diagnostic and testing devices is driving the Asia-Pacific point of care diagnostics market.

The growth of the market in the Rest of the World is gaining importance over the last few years due to the increasing diagnosis of HbA1c and growing demand for glycated hemoglobin analysis. Moreover, the rising number of COVID-19 cases across the region is supporting the demand for POCs diagnosis. In addition, increasing investment in healthcare device manufacturing facilities is strengthening the product portfolio of the regional and global healthcare providers. The escalating demand for in-vitro diagnostics in South America is fueling the sales of POCs across the region. Such factors are expected to augment the market growth over the assessment period.

Segmentation:

The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[healthcare-market]

Hemoglobin A1c Testing Devices Market Size to Expand Significantly by the End of 2026

Transparency Market Research (TMR) has published a new report titled ‘Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global hemoglobin A1c testing devices market was valued at US$ 1,540.7 Mn in 2017. It is projected to expand at a CAGR of over 10.4% from 2018 to 2026. Increase in the geriatric population, employer- sponsored medical programs, rise in medical tourism, and increase in the prevalence and incidence of diabetes contribute to the growth of the market.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1620

Boronate Affinity Chromatography Segment to Expand at a High CAGR

The report offers detailed segmentation of the global hemoglobin A1c testing devices market. Based on technology, the market has been segmented into ion-exchange high performance liquid chromatography (HPLC), immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. The ion-exchange HPLC segment dominated the market in 2017 and is likely to remain dominant in terms of revenues during the forecast period. However, the boronate affinity chromatography segment is likely to expand at a high CAGR during the forecast period. The growth of the segment can be attributed to the low cost of testing compared to the HPLC technology. The linearity range for HbA1c detection using BAC is 5.3% to 17.0%. According to the clinical trials report of the Endocrinología y Nutrición journal, published in 2015, the Afinion AS100 System (Axis-Shield Diagnostics Ltd.) and In2it (Bio-Rad Laboratories, Inc.) are types of boronate affinity chromatography systems that are not affected by the volume of carbamyl Hb produced during Hb testing. This is expected to increase usage of boronate affinity chromatography in the near future.

Enquiry before Buying Hemoglobin A1c Testing Devices Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1620

Point-of-care (POC) Settings Segment to Expand Rapidly

Based on end-user, the market has been classified into laboratory testing and point-of-care (POC) settings. The laboratory settings segment dominated the market in 2017. It is anticipated to remain dominant in terms of revenues during the forecast period. However, the POC settings segment is likely to expand at a high CAGR in the coming years. The growth of the segment can be attributed to an increase in the incidence of hospitalization and rise in the geriatric population. A rise in the number of public-private partnerships is expected to augment the segment in the coming years. According to the American Diabetes Association, point-of-care (POC) testing for HbA1c to offers an opportunity for more timely treatment changes. The International Diabetes Federation (IDF) recommends that the determination of HbA1c either at the POC or in the laboratory should be done before clinical consultation.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1620

Market in Asia Pacific to be Driven by an Increase in the Prevalence and Incidence of Diabetes

In terms of revenue, North America dominated the global hemoglobin A1c testing devices market in 2017. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The ever-increasing population in the region, unmet medical needs, and rise in the prevalence and incidence of diabetes diseases are some of the factors expected to drive the hemoglobin A1c testing devices market in Asia Pacific during the forecast period. A rise in the number of research and development centers for the detection of HbA1c, launch of new DEA devices by major players, favorable reimbursement policies, and expansion of distribution network for HbA1c test devices by key players are anticipated to propel the segment during the forecast period.

Buy now Hemoglobin A1c Testing Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1620&ltype=S

Product Launches is the Primary Strategy Adopted by Market Players

The report also provides profiles of leading players operating in the global hemoglobin A1c testing devices market. Leading market players include Siemens Healthineers, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, and Trinity Biotech plc. Market players have adopted the strategy of product launches to enhance their customer base. For instance, in 2016, Arkray, Inc. introduced the Glucocard product line in Japan. The device will help patients to receive accurate information about their condition and monitor blood glucose levels.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.co.uk/news-releases/single-use-cystoscope-market-to-reach-valuation-of-us-150-mn-by-2031-growing-acceptance-of-patient-ready-instruments-in-urology-to-bolster-demand-tmr-study-818277477.html

https://www.prnewswire.co.uk/news-releases/cell-amp-tissue-preservation-market-to-reach-us-10-04-bn-by-2031-increase-in-demand-for-regenerative-therapies-to-trigger-growth-of-the-market-says-tmr-882063013.html

https://www.prnewswire.co.uk/news-releases/fibrinogen-concentrates-market-to-reach-valuation-of-us-700-mn-by-2031-high-volume-clinical-use-in-coagulation-applications-bolsters-market-growth-tmr-873649318.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research, 90 Sate Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com

[marketresearchstrategy]

Point of Care (PoC) Diagnostics Market Overview, Merger and Acquisitions , Drivers, Restraints and Industry Forecast By 2027

High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of PoC testing devices are key factors contributing to high CAGR of Point of Care (PoC) Diagnostics during forecast period.

The Global Point of Care (PoC) Diagnostics Market is witnessing a remarkable growth owing to an increase in the demands for the products and a tremendous shift in consumer preferences. The high demand is concentrated in the European and North American countries. The report on Global Point of Care (PoC) Diagnostics Market offers a comprehensive analysis of the recent advancements in the Point of Care (PoC) Diagnostics industry and trends driving the growth of the market. The report offers the segmentation of the market on the basis of types, applications, and regions. The report is updated with the latest trends and economic scenario owing to the COVID-19 pandemic. The impact analysis of the pandemic is described in the report. A comprehensive analysis of the present and future impact of COVID-19 on the market, along with a post-COVID-19 scenario, is included in the report.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507

Some of the key players operating in the Point of Care (PoC) Diagnostics market include:

Abbott,  AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher,  EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN and Quidel.

Segments covered in the report:

On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. According to the analysis, North America is expected to dominate the market with the highest market share. Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.

Product Type Outlook (Revenue, USD Million; 2017–2027)

Strips

Meters

Lancets & Lancing Devices

Cardiac Marker Testing Products

Blood Gas/Electrolytes Testing Products

HBA1C Testing Products

Influenza Testing Products

HIV Testing Products

Hepatitis C Testing Products

Sexually Transmitted Disease (STD) Testing Products

Healthcare-Associated Infection (HAI) Testing Products

Respiratory Infection Testing Products

Tropical Disease Testing Products

Other Infectious Disease Testing Products

Platform Type Outlook (Revenue, USD Million; 2017–2027)

Agglutination assays

Biosensors

Dipsticks

Lateral Flow Assays

Microfluidics

Molecular Diagnostics

Solid phase

Prescription Mode Outlook (Revenue, USD Million; 2017–2027)

Prescription-based Testing

OTC Testing

End-User Outlook (Revenue, USD Million; 2017–2027)

Professional Diagnostic Centres

Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings)

Hospitals/Critical Care Centres

Home Care

Research Laboratories

Other End Users

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1507

Beneficial Aspects of the Report:

Global and region forecast of the Point of Care (PoC) Diagnostics market from 2020-2027

In-depth analysis of market dynamics, industry outlook, market size based on types and applications

Details of value chain analysis, supply and demand ratio, production and consumption patterns

SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive players

Detailed insights on competitive landscape and emerging market trends

Research Methodology:

The market report is formulated on the basis of data obtained through extensive primary and secondary research. The data is further validated and verified by industry experts, research analysts, and professionals. The report considers regional demand and supply ratio, investments, market dynamics, capacity, end-use industry trends, and consumer behavior to generate a forecast report. The data is collected from verified sources such as government policies, regulatory published materials, journals, trade magazines, and verified data sources. The report uses advanced analytical tools such as SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide an accurate insight into the market scenario and competitive landscape. This report provides beneficial information to companies and new players to make lucrative business decisions. The market estimates and forecast data have been thoroughly verified through exhaustive primary research.

To read more  about the report – https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

Thank you for reading our report. Reports and Data provides customization of the report as per the needs of the clients. For further inquiry on customization, please connect with us and our team will ensure the report is tailored to fit your requirements.

Browse More Reports:-

Triacetin/Glyceral Triacetate Market Share

Customer Information System (CIS) Market Size

[businessconsultingarticle]

Point of Care (PoC) Diagnostics Market to Reflect Significant Growth during 2020-2027

The Global Point of Care (PoC) Diagnostics Market research report offers accurate insights for the growth prospects of the Point of Care (PoC) Diagnostics market in the forecast years 2020-2027. The report is an all-inclusive study of the Point of Care (PoC) Diagnostics market that offers the readers a better view of the current and emerging market trends through a thorough analysis of the market size, growth trends, supply and demand ratio, market share, sales network and distribution channels, and other key elements.

Furthermore, the report is furnished with the current market scenario with regards to the COVID-19 pandemic. The global public health emergency has disrupted the lives of everyone across the globe. It has also had a substantial impact on the Point of Care (PoC) Diagnostics industry as global supply chains have been disrupted, and the financial scenario is tight. The report assesses the initial and future impact of the pandemic on the market and its key segments to offer an accurate futuristic outlook for remuneration in a post-COVID-19 scenario.

Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507

Scope of the Market Report: The report offers a holistic overview of the Point of Care (PoC) Diagnostics industry that offers all the essential information. Furthermore, the market is segmented into product types, applications, end-user industries, and regions. The report is formulated by extensive primary and secondary research and backed by the verified data from industry experts and professionals. It also sheds light on the market size and analyzes the market position. Along with this, the report extensively studies the competitive landscape in the market and profiles the key players of the industry.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

Abbott, F. Hoffmann-La Roche and Siemens Healthineers.

For the purpose of the study, this Reports and Data has segmented the Global Point of Care (PoC) Diagnostics Market on the basis of product type, platform type, prescription mode, end user and the regional outlook:

Product Type (Revenue, USD Million; 2016–2026)

Glucose Monitoring Products

Strips

Meters

Lancets & Lancing Devices

Cardiometabolic Testing Products

Cardiac Marker Testing Products

Blood Gas/Electrolytes Testing Products

HBA1C Testing Products

Prescription Mode (Revenue, USD Million; 2016–2026)

Prescription-based Testing

OTC Testing

End User (Revenue, USD Million; 2016–2026)

Professional Diagnostic Centres

Clinical Laboratories (Outpatient Healthcare &     Ambulatory Care Settings)

Hospitals/Critical Care Centres

Home Care

Research Laboratories

Other End Users

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1507

Additionally, the report covers an analysis of the key market regions where the market has substantial size and share. Along with the regions, the report also offers a country-wise analysis to enable better comprehension of the market competition. The key regions covered in the report are as follows:

North America     (U.S., Canada)

Europe     (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific     (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America     (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Summary of the Report:

The report offers a growth estimate for 8 years along     with a forecast for market valuation

A thorough qualitative and quantitative analysis of the     Global Point of Care (PoC) Diagnostics Market

Advanced analytical tools such as SWOT analysis and     Porter’s Five Forces analysis along with feasibility analysis and     investment return analysis

Comprehensive study of the prominent players engaged in     the market along with their product portfolio and business expansion strategies

Strategic recommendations for new entrants and     established players

Extensive analysis of drivers, restraints, limitations,     growth prospects and opportunities, and threats

In-depth regional analysis to offer a panoramic view of     the Point of Care (PoC) Diagnostics market along with a better     understanding of the market’s competitive scenario

To read more about the report, visit @ https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

Thank you for reading our report. The customization of the report is available as per your research needs. Please get in touch with us, and our team will ensure you get the report tailored as per your requirements.

Similar Report:

1. Urinalysis Market Size, Trends & Analysis, By Product, By Application, By End-Use Vertical, By Region, Segment Forecasts To 2027

2. Diagnostic Biomarkers Market Size, Trends & Analysis, By Product, By Form and By Application, Forecasts To 2027

[mayurpande6990]

In this report, we provide assessment of market definition along with the identification of key players and an analysis of their Production, Revenue, Price, Cost and Gross Margin their SWOT analysis for this market during the forecast period. Quantitative analysis of the industry from 2014 to 2025 by Region, Type, Application. Consumption assessment by regions. Industrial chain,upstream and downstream situation involved in this market.

[healthcaremarketforecasters]

POC HbA1C Testing Market is Expected to Reach Over CAGR of 8.60% during 2017-2021

About global POC HbA1C testing

POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. Hemoglobin (Hb) is the oxygen-carrying pigment which provides red color to the blood. The measurement of HbA1c helps in monitoring the average blood sugar level. POC testing kits for HbA1c has been introduced in the market for efficient and faster detection of diabetes and pre-diabetes.

The global POC HbA1C testing market to grow at a CAGR of 8.60% during the period 2017-2021.

Download sample Copy of This Report at: https://www.radiantinsights.com/research/global-poc-hba1c-testing-market-2017-2021/request-sample

Covered in this report

The report covers the present scenario and the growth prospects of the global POC HbA1C testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Global POC HbA1C Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendorsoperating in this market.

Access This Full Report @ https://www.radiantinsights.com/research/global-poc-hba1c-testing-market-2017-2021

Market driver

Increasing equipment rental agreements

For a full, detailed list, view our report

Market challenge

Lack of skilled professionals to conduct POC diagnosis

For a full, detailed list, view our report

Market trend

Increasing online marketing services for POC diagnosis

For a full, detailed list, view our report

Key vendors

Abbott

Alere

Bio-Rad Laboratories

Other prominent vendors

ARKRAY

Diazyme Laboratories

EKF Diagnostics

OSANG Healthcare

Menarini Diagnostics

PTS Diagnostics

F. Hoffmann-La Roche

Siemens

Tosoh Bioscience

Trinity Biotech

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit Radiant Insights

Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com     Blog URL: http://www.radiantinsightsinc.blogspot.com

[newinnovationalmarketresearch]

Point of Care (POC) Diagnostics/Testing Market Research (2020-2025) Report by Size, Share, Revenue, Business Growth, Demand and Applications

Point of Care (POC) Diagnostics/Testing Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Point-of-care (POC) diagnostics is referred to as medical testing at or near the site of patient care. These tests are developing in analytical scope, clinical application, and could be easily performed at the bedside. The test mainly involves blood and urine testing. The results of the test are obtained in a very short period.

 Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market/request-sample

 The key driving factors responsible for the growth of Point of Care (POC) Diagnostics/Testing market :

 The factors that are playing a major role in the growth of point of care (POC) diagnostics market are the occurrence of chronic diseases, rising inclination toward home healthcare, private investment and project funding towards the development of new products, government initiatives to increase the adoption of POC devices, and efficient workflow process. However, disinclination among patients to change current treatment practices is a factor that is restraining overall market growth.

 Point of care (POC) testing market is segmented based on product type, prescription mode, end user, and region. Tumor/cancer markers, fecal occult testing kits, glucose monitoring kits, urinalysis testing kits, drugs of abuse testing kits, cholesterol test strips, hematology testing kits, cardiometabolic monitoring kits, pregnancy and fertility testing kits, infectious diseases testing kits, coagulation monitoring kits, and other product types could be explored in point of care diagnostics market in the forecast period.

 Cardiometabolic monitoring kits comprise cardiac markers, blood gas/electrolytes testing kits, hba1c testing kits, lipids testing. Pregnancy and fertility testing kits sector comprise pregnancy-testing kits, fertility-testing kits. Also, infectious diseases testing kits sector comprise influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases (STDs) testing kits, tropical diseases testing kits, healthcare-associated infections (HAIs), respiratory infections testing kits, and others. Coagulation monitoring kits sector comprise prothrombin time (PT/INR) testing kits and activated clotting time (ACT/APTT) testing kits.

 Based on the prescription mode, over-the-counter (OTC) testing kits and prescription-based testing kits could classify point of care (POC) diagnostics in the forecast period. Prescription-based testing kits segment accounted for the substantial market share of the point of care testing and is estimated to remain dominant over the forecast period. The reason being, rising chronic diseases and lack of awareness of the point of care (POC) testing.

 View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market

[dpiresearchofficial]

Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynamic of point of–care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field. The global point of care testing market is projected to reach US$ 38 Billion by 2022, at a CAGR of XX% from 2016 to 2022. The global market is mainly driven by increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home–based POC devices, and technological advancements with regard to development of advanced, faster, and easy to–use devices are stimulating the demand for POCT This report titled “Point of Care Testing – Global Analysis & Market Forecasts” provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals and collaboration deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market. The following 13 segments of the point of care testing market are detailed with market size and six year forecast. Blood Glucose Testing Cardiac Markers Testing Lipid Panel/Cholesterol Testing Blood Coagulation Testing Infectious Disease Testing Urinalysis Testing Drug of Abuse Testing Pregnancy & Fertility Testing Cancer Markers Testing Critical Care Testing HbA1C Testing Clinical Chemistry Testing Bilirubin Testing

[healthcare-market]

Hemoglobin A1c Testing Market Size, Share, Growth Trends, and Forecast Analysis

Transparency Market Research (TMR) has published a new report titled, ‘Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Hemoglobin A1c Testing Devices market was valued at US$ 1,676.3 Mn in 2018 and is projected to expand at a CAGR of 10.7% from 2019 to 2027.

Overview

· Hemoglobin A1c testing devices are used to determine and monitor hemoglobin A1c levels in diabetic patients. For more than 500 million people affected with diabetes across the world, blood testing has become a routine part of managing the disease. A1C tests measure average blood glucose over the past two to three months. It is also known as glycosylated hemoglobin test, glycohemoglobin test, glycated hemoglobin test, or A1C.

· In terms of technology, ion-exchange HPLC segment dominated the market owing to the establishment of this technology as gold standard method of determination of HbA1c due to its excellent specificity and reproducibility. A clinical study by the company indicated that 205 patients with SC and diabetes were analyzed using immunoassay and HPLC instrument. The immunoassay study produced lower HBA1c compared to HPLC method.

· In terms of end-user, hemoglobin A1c testing devices are mostly used in laboratories and point-of-care units such as hospitals, clinics, home care, and others.

· North America dominated the global Hemoglobin A1c Testing Devices market in 2018 and the trend is anticipated to continue during the forecast period. High prevalence of different types of diabetes and rise in the geriatric population in the region are some of the factors augmenting the market in North America are expected to drive the market in North America.

· Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast period

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73900

Recent approval of HBA1C tests in year 2018 to Drive Market

· A1CNow systems developed by PTS Diagnostics got approved in year 2018 which provides accurate A1C results in the office or home comes in a convenient 2-test pack or 4-test pack.

· Abbott laboratories got its Afinion assay product approved which is the first-ever rapid point-of-care test approved to help diagnose diabetes and assess patients’ risk of developing the disease

· Bio-Rad Laboratories, Inc product VARIANT II System got its approval which offers fully automated high-volume hemoglobin A1c and β-thalassemia testing, with Clinical Data Management Software and a LIS interface.

Faster adoption and Increase in point-of-care testing to Drive Market

· Point-of-care testing provides results within time limit, offers consumer convenience, reduces needle stick injuries, and minimizes contamination

· It has also led to development of the smaller devices, portable, and minimally invasive product. Hence, several laboratories are being converted into POC testing laboratories, as these can be operated by person not necessarily biologist. POC laboratories are also considered an easy way of providing clinical microbiology testing for people far away from core laboratories in developed and developing countries

Ion-exchange HPLC Segment to Dominate Market

· Based on technology, the global Hemoglobin A1c Testing Devices market has been divided into Ion-exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, and others. The Ion-exchange HPLC, dominates the market in year 2018, owing to the excellent specificity and reproducibility, and ability to detect the most common Hb variants through HPLC. According to Bio-Rad Laboratories, Inc., the American Diabetes Association (ADA) recommends HbA1c equal to or more than 6.5% to diagnose diabetes using HPLC. ADA considers HPLC as the gold standard method for the determination of HbA1c.

· However, cost of HbA1c treatment using HPLC method compared to other techniques is high, which is likely to induce patients to adopt other techniques.

Request for Analysis of COVID19 Impact on Hemoglobin A1c Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73900

Point-of-care settings to be Highly Lucrative Segment

· In terms of end-user, the global Hemoglobin A1c Testing Devices market has been classified into laboratories, and point-of-care settings.

· The laboratories segment dominated the Hemoglobin A1c Testing Devices market owing to rise in the number of cases of diabetes type II disorders, enhanced diagnostic care services, and availability of a wide range of services at a single site in commercial laboratories. However, rise in diagnostic costs and changes in reimbursement models are estimated to hamper the segment during the forecast period.

· The point-of-care settings segment expected to expand at faster pace during forecast period. According to the American Diabetes Association, point-of-care (POC) testing for HbA1c to offers the opportunity for more timely treatment changes. The International Diabetes Federation (IDF) recommends determination of HbA1c either at the POC or in the laboratory should be done before clinical consultation.

North America to Dominate Global Market

· In terms of region, the global Hemoglobin A1c Testing Devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Hemoglobin A1c Testing Devices market in 2018, followed by Europe.

· North America accounted for major share of the global Hemoglobin A1c Testing Devices market in 2018, owing to increase in demand for direct enzyme assay techniques; technological advancements in HPLC technology; and rise in the adoption of various chromatographic devices by hospitals, diagnostic labs, and clinics are likely to propel the market in the region during the forecast period

· The Hemoglobin A1c Testing Devices market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to increasing population in the region, unmet medical needs, rise in prevalence and incidence of diabetes diseases are some of the factors expected to drive the hemoglobin A1c testing devices market in Asia Pacific during the forecast period. Moreover, development in the field of science, high disposable income, and rise in per capita health care expenditure propel the market in the region.

Buy now Hemoglobin A1c Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=73900&ltype=S

Competitive Landscape

· The global Hemoglobin A1c Testing Devices market is fragmented in terms of number of players. Key players in the global market include Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, Trinity Biotech plc. and other prominent players.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/global-corneal-topographers-market-is-likely-to-be-driven-by-high-prevalence-of-diabetes-and-rise-in-aging-population-tmr-301237312.html

https://www.prnewswire.co.uk/news-releases/rising-sales-of-indwelling-voice-prostheses-spurs-growth-momentum-of-voice-prosthesis-devices-market-m-amp-a-activities-key-strategy-for-consolidation-tmr-862220741.html

https://www.prnewswire.com/news-releases/novel-use-to-treat-patients-of-covid-19-to-expand-horizon-of-blood-purification-equipment-market-swift-fda-approvals-for-emergency-use-attract-players-for-product-innovation-tmr-301244584.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

[researchtrendingmarket-blog]

Point-of-care Testing (POCT) Market Strategic Insights and key Business Influencing Factors | Major Players –  Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics.

Point-of-care Testing (POCT) Market driving the growth of this market include the rising prevalence of modern lifestyle, increase in chronic and infectious diseases, advancement in technology, scope for unmet medical needs and emerging POCT device. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein. On the other hand, rising costs of POCT device and low reimbursement scenario are regulatory hurdles that may hinder the growth of the market.

APAC POCT Device Market is expected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

 Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=apac-point-care-testing-poct-market

Market Key Points: APAC Point-of-Care Testing (POCT)

Hoffmann La Roche Diagnostics Limited is dominating the APAC POCT device market major players followed by Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc., Werfenlife and others.

High Temperature Elastomer Market Size, Status and Forecast 2026

 Market Overview

 Manufacturers Profiles

 Point-of-care Testing (POCT) Sales, Revenue, Market Share and   Competition by Manufacturer

 Point-of-care Testing (POCT) Market Analysis by Regions

 North America Point-of-care Testing (POCT) by Countries

 Europe Point-of-care Testing (POCT) by Countries

 Asia-Pacific Point-of-care Testing (POCT) by Countries

 South America Point-of-care Testing (POCT) by Countries

  Middle East and Africa Point-of-care Testing (POCT) by Countries

  Point-of-care Testing (POCT) Market Segment by Type

 Point-of-care Testing (POCT) Market Segment by Application

 Point-of-care Testing (POCT) Market Forecast

 Sales Channel, Distributors, Traders and Dealers

 Research Findings and Conclusion

 Appendixes

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=apac-point-care-testing-poct-market

Market Segmentation: APAC Point-of-care Testing (POCT) Market

The APAC Point-of-care Testing (POCT) Market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.

On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.

Based on prescription mode, the APAC Point-of-care Testing (POCT) Market is segmented into prescription based testing and over-the-counter (OTC) testing.

On the basis of distribution channel, the market is segmented into direct tenders and retail.

On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.

Competitive Landscape: APAC Point-of-care Testing (POCT) Market

Global Point-of-care Testing (POCT) Market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For instance, in June 2015, Roche launched its Cardiac point-of-care (POC) troponin test for the cobas h 232 system which is available for countries which accept the CE Mark. This product has improved accuracy at low concentrations and it will help in diagnosis of heart attack patients with high mortality risk. The report includes company share data for different countries including China, Japan, India, South Korea, Australia and Singapore.The APAC point-of-care testing market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the major players operating in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, AccuBioTech Co., Ltd., bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical among others.

Reasons to Purchase this Report:

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/Countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=apac-point-care-testing-poct-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[marketresearchstrategy]

Point of Care (PoC) Diagnostics Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2027

High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of PoC testing devices are key factors contributing to high CAGR of Point of Care (PoC) Diagnostics during forecast period.

The Global Point of Care (PoC) Diagnostics Market is witnessing a remarkable growth owing to an increase in the demands for the products and a tremendous shift in consumer preferences. The high demand is concentrated in the European and North American countries. The report on Global Point of Care (PoC) Diagnostics Market offers a comprehensive analysis of the recent advancements in the Point of Care (PoC) Diagnostics industry and trends driving the growth of the market. The report offers the segmentation of the market on the basis of types, applications, and regions. The report is updated with the latest trends and economic scenario owing to the COVID-19 pandemic. The impact analysis of the pandemic is described in the report. A comprehensive analysis of the present and future impact of COVID-19 on the market, along with a post-COVID-19 scenario, is included in the report.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507

Some of the key players operating in the Point of Care (PoC) Diagnostics market include:

Abbott,  AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher,  EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN and Quidel.

Segments covered in the report:

On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. According to the analysis, North America is expected to dominate the market with the highest market share. Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.

Product Type Outlook (Revenue, USD Million; 2017–2027)

Strips

Meters

Lancets & Lancing Devices

Cardiac Marker Testing Products

Blood Gas/Electrolytes Testing Products

HBA1C Testing Products

Influenza Testing Products

HIV Testing Products

Hepatitis C Testing Products

Sexually Transmitted Disease (STD) Testing Products

Healthcare-Associated Infection (HAI) Testing Products

Respiratory Infection Testing Products

Tropical Disease Testing Products

Other Infectious Disease Testing Products

Platform Type Outlook (Revenue, USD Million; 2017–2027)

Agglutination assays

Biosensors

Dipsticks

Lateral Flow Assays

Microfluidics

Molecular Diagnostics

Solid phase

Prescription Mode Outlook (Revenue, USD Million; 2017–2027)

Prescription-based Testing

OTC Testing

End-User Outlook (Revenue, USD Million; 2017–2027)

Professional Diagnostic Centres

Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings)

Hospitals/Critical Care Centres

Home Care

Research Laboratories

Other End Users

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1507

Beneficial Aspects of the Report:

Global and region forecast of the Point of Care (PoC) Diagnostics market from 2020-2027

In-depth analysis of market dynamics, industry outlook, market size based on types and applications

Details of value chain analysis, supply and demand ratio, production and consumption patterns

SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive players

Detailed insights on competitive landscape and emerging market trends

Research Methodology:

The market report is formulated on the basis of data obtained through extensive primary and secondary research. The data is further validated and verified by industry experts, research analysts, and professionals. The report considers regional demand and supply ratio, investments, market dynamics, capacity, end-use industry trends, and consumer behavior to generate a forecast report. The data is collected from verified sources such as government policies, regulatory published materials, journals, trade magazines, and verified data sources. The report uses advanced analytical tools such as SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide an accurate insight into the market scenario and competitive landscape. This report provides beneficial information to companies and new players to make lucrative business decisions. The market estimates and forecast data have been thoroughly verified through exhaustive primary research.

To read more  about the report – https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

Thank you for reading our report. Reports and Data provides customization of the report as per the needs of the clients. For further inquiry on customization, please connect with us and our team will ensure the report is tailored to fit your requirements.

Browse More Reports:-

Triacetin/Glyceral Triacetate Market Share

Customer Information System (CIS) Market Size

[businessconsultingarticle]

Point of Care (PoC) Diagnostics Market Research Study, Growth Factors, Statistics, Forecasting 2027

According to the recent marketing research of Reports and Data, the global Point of Care (PoC) Diagnostics market size was estimated to be USD 26.28 Billion in 2019 and is anticipated to surpass USD 55.35 Billion by year 2027, registering a CAGR of 9.6%. The Centers for Disease Control and Prevention, in U.S. estimates 100 million adults are affected by diabetes or pre-diabetes at the present. Cardiovascular diseases (CVD) account for about 800,000 deaths within the country. On a mean, U.S. records the death of 1 person every 40 seconds from CVD. It also causes 3.9 million deaths in Europe and around 1.8 million deaths within the European Union. Point-of-care (POC) diagnostics is a medical diagnostic assay that allows physicians and medical staff to accurately attain lab-quality diagnostic leads to real-time. In other words, the results are available within minutes instead of hours. With portable blood analysers, testing near patient streamlines the diagnostic process and aids to make sure patients receive the foremost effectual and efficient care when and where needed. Point-of-care (POC) diagnostic testing allows medical staff to form speedy treatment decisions when analysing a patient’s condition or monitoring a treatment reaction. By streamlining the testing process, physicians can specialise in providing effective, quality patient care. Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1507

Point of Care (PoC) Diagnostics Market Dynamics Near patient testing allows quite just bedside testing. It enables clinicians to enhance efficiency and productivity. These diagnostic tools are possibly costlier than traditional ones but are more accurate and even lower staff burden by driving the main target back to the patient. Major developments within the field of Point-of-Care (PoC) diagnostics include PixCell Medical’s acceptance of the FDA 510(k) approval for its POC the HemoScreen Haematology Analyser, in 2018. HemoScreen Haematology Analyser enables physicians to form accurate decisions with increased rapidity. Predominance of infectious diseases, swelling occurrence of target diseases, and stronger preference for home healthcare in developing economies across the planet are increasing the adoption of PoC diagnostics products. Greater investment by public organizations is additionally acting as driving factor for the expansion of the market. As an example , in 2018, the Massachusetts Medical Device Development Center used a USD 7.9 million grant from the National Institute of Health (NIH) to determine a M2D2 which essentially helps inventors leading promising new PoC devices and technologies handling heart, lung, blood and sleep disorders. Point of Care (PoC) Diagnostics Market: Regional Outlook

North America is predicted to account for the 41.1% of the global Point of Care (PoC) Diagnostics market due to CVD prevalence and chronic disorders due to unhealthy lifestyle. Rapid FDA approvals and streamlined government regulations related to development of healthcare will also supplement the growth. Europe Point of Care (PoC) Diagnostics market size follows that of North America with a share of 33.1% thanks to the increased adoption of these devices, rise in awareness about medical innovative, increased applications of point of care diagnostic devices, and rapidly aging population including increase in incidences of diabetes and liver diseases.

Impact of COVID-19 on Point of Care (PoC) Diagnostics Market:

COVID-19 has affected various business aspects and therefore the healthcare sector has been the most considerably impacted by the crisis. The WHO has declared COVID-19 to be a worldwide pandemic and therefore the healthcare industry has resorted to variety of emergency undertakings to assist the overall population in fighting the deadly disease. While hospitals and clinics are filled to capacity, trying to assist ailing patients, most patients are asked to remain away from healthcare institutions if not faced with dire emergency as hospitals are currently highly contagious and the coronavirus can negatively impact the health condition of weak individuals. The growth of PoC Diagnostics market is predicted to register a huge surge in demand as COVID-19 crisis creates a substantial opportunity for near patient tests.

To identify the key trends in the industry, click on the link below @ https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

Point of Care (PoC) Diagnostics Market: Key Players

Abbott

F. Hoffmann-La Roche

Siemens Healthineers

Report Highlights:

Detailed overview of the market

Evolving Point of Care (PoC) Diagnostics market dynamics

In-depth Point of Care (PoC) Diagnostics market classification

Historical, present, and anticipated Point of Care (PoC) Diagnostics market size and share in terms of volume and value

Recent Point of Care (PoC) Diagnostics market trends and advances

Competitive landscape

Strategies adopted by key players and products portfolio

Segments, sub-segments, and geographic regions exhibiting growth prospects

A neutral and global perspective on Point of Care (PoC) Diagnostics market performance

Point of Care (PoC) Diagnostics Market: Segmentation

For the purpose of the study, this Reports and Data has segmented the Global Point of Care (PoC) Diagnostics Market on the basis of product type, platform type, prescription mode, end user and the regional outlook:

Product Type (Revenue, USD Million; 2017–2027)

Glucose Monitoring Products

Cardiometabolic Testing Products

Infectious Disease Testing Products

Coagulation Testing Products

PT/INR Testing Products

Activated Clotting Time (ACT/APTT) Testing Products

Pregnancy and Fertility Testing Products

Pregnancy Testing Products

Fertility Testing Products

Tumour/Cancer Marker Testing Products

Urinalysis Testing Products

Cholesterol Testing Products

Haematology Testing Products

Drugs-of-Abuse Testing Products

Fecal Occult Testing Products

Other POC Products

Strips

Meters

Lancets & Lancing Devices

Cardiac Marker Testing Products

Blood Gas/Electrolytes Testing Products

HBA1C Testing Products

Influenza Testing Products

HIV Testing Products

Hepatitis C Testing Products

Sexually Transmitted Disease (STD) Testing Products

Healthcare-Associated Infection (HAI) Testing Products

Respiratory Infection Testing Products

Tropical Disease Testing Products

Other Infectious Disease Testing Products

Platform Type (Revenue, USD Million; 2017–2027)

Agglutination assays

Biosensors

Dipsticks

Lateral Flow Assays

Microfluidics

Molecular Diagnostics

Solid phase

Prescription Mode (Revenue, USD Million; 2017–2027)

Prescription-based Testing

OTC Testing

End User (Revenue, USD Million; 2017–2027)

Professional Diagnostic Centres

Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings)

Hospitals/Critical Care Centres

Home Care

Research Laboratories

Other End Users

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1550

Regional Outlook (Revenue, USD Million; 2017–2027)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

U.S.

Canada

Germany

UK

Spain

France

Italy

Rest of Europe

Japan

China

India

Australia

Rest of Asia-Pacific

Brazil

Mexico

Thank you for reading our report. The customization of the report is available as per your research needs. Please get in touch with us, and our team will ensure you get the report tailored as per your requirements.

Similar Report:

1. Urinalysis Market Size, Trends & Analysis, By Product, By Application, By End-Use Vertical, By Region, Segment Forecasts To 2027

2. Diagnostic Biomarkers Market Size, Trends & Analysis, By Product, By Form and By Application, Forecasts To 2027

[acquiremarketresearch]

POC HbA1C Testing Market | Size, Share, Trends | Industry Analysis |Acquire Market Research

Global  POC HbA1C Testing Market Research Report 2020, presented by Acquire Market Research will help you make informed decisions, know opportunities, plan new projects, plan effective business strategies, explore drivers and restraints and give you a vision on the industry forecast. The report provides the latest information on the present and the future industry trends, allowing the readers to identify the products and services, hence driving the revenue growth and profitability. With this POC HbA1C Testing market report, all the participants and the vendors will be aware of the growth factors, shortcomings, threats, and the lucrative opportunities that the market will offer in the near future. The report also features the revenue; industry size, share, production volume, and consumption in order to gain insights about the politics and tussle of gaining control of a huge chunk of the market share. Interpret a Competitive Outlook Analysis with Sample Report: https://www.acquiremarketresearch.com/sample-request/164894/ Scope of the Report: The POC HbA1C Testing market report also shares details of production value with some important factors, upstream raw materials, and downstream demand that can lead to market growth. What distinction strategist should bring about services or products understanding behavior along with the POC HbA1C Testing market competition movements to create them appealing the analysis? The Major Players Covered in this Report: Abbott, Roche, Bio-Rad, Siemens, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, PTS Diagnostics, Erba Diagnostics, EKF Diagnostics, OSANG Healthcare & More. By the product type, the market is primarily split into: Product Type By the end-users/application, this report covers the following segments: Application Type Regional Analysis Market: North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Grab Your Report at an Impressive Discount! Please click here @ https://www.acquiremarketresearch.com/discount-request/164894/ Key Areas of Focus:  Major trends. Market and pricing issues. Customary business practices. Government presence in the market. The extent of commercial in the market. Involvement of functional disciples in market performance. Geographic limitations. Distribution, scheduling, performance, and supplier requirements. The main points which are answered and covered in this Report are- 1. What will be the total market size in the coming years? 2. What will be the key factors which will be overall affecting the industry? 3. What are the various challenges addressed? 4. Which are the major companies included? Browse the full report Description, TOC and Table of Figure @ https://www.acquiremarketresearch.com/industry-reports/poc-hba1c-testing-market/164894/ In the end, the objective of the market research report is the current status of the market and in accordance classifies it into a few objects. The report takes into consideration the first market players in every area from over the globe.

[marketresearchandconsultant-blog]

Point of Care Testing Market Foraying into Emerging Economies 2016 – 2022

Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynamic of point of–care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field.

 Request for a sample of report @

https://mindaspiremarketresearch.com/request-sample/report/point-of-care-testing-global-market-analysis

 The global point of care testing market is projected to reach US$ 38 Billion by 2022, at a CAGR of XX% from 2016 to 2022. The global market is mainly driven by increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home–based POC devices, and technological advancements with regard to development of advanced, faster, and easy to–use devices are stimulating the demand for POCT

This report titled “Point of Care Testing – Global Analysis & Market Forecasts” provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals and collaboration deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.

 The following 13 segments of the point of care testing market are detailed with market size and six year forecast

 • Blood Glucose Testing

• Cardiac Markers Testing

• Lipid Panel/Cholesterol Testing

• Blood Coagulation Testing

• Infectious Disease Testing

• Urinalysis Testing

• Drug of Abuse Testing

• Pregnancy & Fertility Testing

• Cancer Markers Testing

• Critical Care Testing

• HbA1C Testing

• Clinical Chemistry Testing

• Bilirubin Testing

 Ask an Analyst @

https://mindaspiremarketresearch.com/inquire/report/point-of-care-testing-global-market-analysis

 This report also gives access to significant data such as:

• Market Growth Drivers in the Point of Care Testing Market

• Challenges in the Point of Care Testing Market

• Current Market Trends

• Market Forecasting for the Coming Years

• Merger & Acquisitions between major companies

• Distribution Agreement

• Licensing Deals

• Collaboration Deals